Vaccines have long been seen as a potentially attractive option for treating cancer. Now a group targeting a peptide that plays a key role in CML think they may be onto a winner.
Cancer vaccine for CML shows promise
Related Articles
Systems & Services
Europe’s rare cancer community calls for a more radical approach
Cutting Edge
We told you so: How the persistence of
Drug Watch
Leave a Reply